We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
+15.38%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
AUM
$111M
AUM Growth
+$20M
Cap. Flow
+$10.4M
Cap. Flow %
9.41%
Top 10 Hldgs %
75.97%
Holding
491
New
51
Increased
136
Reduced
58
Closed
33

Sector Composition

1 Healthcare 12.42%
2 Technology 2.36%
3 Financials 1.76%
4 Consumer Discretionary 1.49%
5 Industrials 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$883B
$34M 30.59%
101,045
-127
-0.1% -$42.3K
EFV icon
2
iShares MSCI EAFE Value ETF
EFV
$26B
$11.9M 10.69%
294,174
+1,579
+0.5% +$65.3K
SPEM icon
3
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$16.9B
$9.52M 8.57%
260,294
-2,406
-0.9% -$87.8K
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$6.74M 6.07%
79,204
-218
-0.3% -$11K
TIP icon
5
iShares TIPS Bond ETF
TIP
$14.5B
$5.99M 5.4%
+47,370
New +$5.95M
IUSV icon
6
iShares Core S&P US Value ETF
IUSV
$27.1B
$4.29M 3.86%
79,020
+4,519
+6% +$247K
SHY icon
7
iShares 1-3 Year Treasury Bond ETF
SHY
$25.7B
$3.4M 3.06%
39,239
-2,202
-5% -$191K
IJH icon
8
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.97M 2.68%
80,235
-45
-0.1% -$1.68K
SPNE
9
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$2.84M 2.56%
198,439
+59,468
+43% +$720K
TNDM icon
10
Tandem Diabetes Care
TNDM
$1.14B
$2.76M 2.49%
24,327
+851
+4% +$89.4K
OXFD
11
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$1.59M 1.43%
135,649
+16,746
+14% +$222K
CDNA icon
12
CareDx
CDNA
$2.05B
$1.23M 1.11%
32,358
+15,835
+96% +$535K
MMM icon
13
3M
MMM
$83.8B
$1.03M 0.93%
7,725
-317
-4% -$42.6K
QDEL icon
14
QuidelOrtho
QDEL
$1.21B
$1.03M 0.93%
4,683
+153
+3% +$34.1K
KRMD icon
15
KORU Medical Systems
KRMD
$190M
$937K 0.84%
129,731
+3,157
+2% +$28K
KRYS icon
16
Krystal Biotech
KRYS
$10.4B
$813K 0.73%
18,894
+1,525
+9% +$66.2K
USB icon
17
US Bancorp
USB
$99.3B
$755K 0.68%
21,052
+4,568
+28% +$167K
HALO icon
18
Halozyme
HALO
$9.16B
$723K 0.65%
27,515
+26,869
+4,159% +$748K
AAPL icon
19
Apple
AAPL
$4.86T
$711K 0.64%
6,138
+90
+1% +$9.82K
SPY icon
20
State Street SPDR S&P 500 ETF Trust
SPY
$776B
$685K 0.62%
2,045
-3
-0.1% -$994
MSFT icon
21
Microsoft
MSFT
$2.93T
$626K 0.56%
2,976
-118
-4% -$24.8K
XEL icon
22
Xcel Energy
XEL
$49.2B
$570K 0.51%
8,261
+57
+0.7% +$3.89K
AMZN icon
23
Amazon
AMZN
$2.66T
$482K 0.43%
3,060
ABT icon
24
Abbott
ABT
$174B
$469K 0.42%
4,309
+11
+0.3% +$1.12K
PG icon
25
Procter & Gamble
PG
$349B
$460K 0.41%
3,307
+16
+0.5% +$2.12K

Similar funds

HighMark Wealth Management's Q3 2020 Portfolio in Review

As of Q3 2020, HighMark Wealth Management held 491 positions worth $111M, up 22% from $91M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

HighMark Wealth Management deployed $10.4M of net new capital in Q3 2020, opening 51 new positions and adding to 136 existing holdings. Its largest new stake was iShares TIPS Bond ETF: 47,370 shares worth $5.99M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $191K trimmed.

  • HighMark Wealth Management's largest Q3 2020 buy was iShares TIPS Bond ETF: 47,370 shares worth $5.99M.
  • HighMark Wealth Management added most to Halozyme in Q3 2020, an estimated $748K increase.
  • HighMark Wealth Management's biggest Q3 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $191K.
  • HighMark Wealth Management fully exited Micron Technology in Q3 2020, selling an estimated $21K.
  • HighMark Wealth Management's ten largest holdings make up 76% of its $111M portfolio in Q3 2020.
  • HighMark Wealth Management opened 51 new positions and closed 33 in Q3 2020.
  • HighMark Wealth Management's portfolio value rose 22% quarter-over-quarter to $111M.

Based on HighMark Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.